Clinical Trials Browser

Fanconi Anemia, Complementation Group D1 × Gastrointestinal × Clear all

Fanconi Anemia, Complementation Group D1, Pancreatic Neoplasms, Peutz-Jeghers Syndrome

NCT01286987 2019-01-10

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

BreastClassical hematologyGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Fanconi Anemia, Complementation Group D1, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Ewing, Small Cell Lung Carcinoma

NCT00580021 2016-01-28

Clinical Outcomes in Hereditary Cancer

Withdrawn

BreastClassical hematologyGastrointestinal

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Pancreatic Neoplasms

Clinical Trials

CAPS 3

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Clinical Outcomes in Hereditary Cancer